Cover Image
市場調查報告書

A. Menarini Industrie Farmaceutiche Riunite Srl - 產品平台分析

A. Menarini Industrie Farmaceutiche Riunite Srl - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 251514
出版日期 內容資訊 英文 40 Pages
訂單完成後即時交付
價格
Back to Top
A. Menarini Industrie Farmaceutiche Riunite Srl - 產品平台分析 A. Menarini Industrie Farmaceutiche Riunite Srl - Product Pipeline Review - 2015
出版日期: 2015年05月29日 內容資訊: 英文 40 Pages
簡介

A. Menarini Industrie Farmaceutiche Riunite Srl 是總公司設立於義大利的製藥企業,提供心血管系統疾病,消化器官系統疾病,抗菌劑,呼吸系統,糖尿病,發炎等領域各種形式的產品。

本報告提供A. Menarini Industrie Farmaceutiche Riunite Srl 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

A. Menarini Industrie Farmaceutiche Riunite Srl 基本資料

  • A. Menarini Industrie Farmaceutiche Riunite Srl 概要
  • 主要資訊
  • 企業資料

A. Menarini Industrie Farmaceutiche Riunite Srl :R&D概要

  • 主要的治療範圍

A. Menarini Industrie Farmaceutiche Riunite Srl :開發平台分析

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

A. Menarini Industrie Farmaceutiche Riunite Srl :開發中產品概況

  • 後期階段產品開發中產品
    • 登記申請前階段的產品/聯合治療模式
    • 第Ⅲ相的產品/聯合治療模式
  • 臨床階段的開發中產品
    • 第Ⅱ相的產品/聯合治療模式
    • 第Ⅰ相的產品/聯合治療模式

A. Menarini Industrie Farmaceutiche Riunite Srl :藥物簡介

  • (dexketoprofen + tramadol hydrochloride)
  • ibodutant
  • sabarubicin
  • fasitibant chloride
  • nepadutant
  • ranolazine ER

A. Menarini Industrie Farmaceutiche Riunite Srl :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

A. Menarini Industrie Farmaceutiche Riunite Srl :最近的開發平台資訊

A. Menarini Industrie Farmaceutiche Riunite Srl :暫停開發中的計劃

A. Menarini Industrie Farmaceutiche Riunite Srl :開發中止的開發中產品

A. Menarini Industrie Farmaceutiche Riunite Srl :企業理念

A. Menarini Industrie Farmaceutiche Riunite Srl :總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07098CDB

Summary

Global Markets Direct's, 'A. Menarini Industrie Farmaceutiche Riunite Srl - Product Pipeline Review - 2015', provides an overview of the A. Menarini Industrie Farmaceutiche Riunite Srl's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of A. Menarini Industrie Farmaceutiche Riunite Srl's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of A. Menarini Industrie Farmaceutiche Riunite Srl including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of A. Menarini Industrie Farmaceutiche Riunite Srl's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the A. Menarini Industrie Farmaceutiche Riunite Srl's pipeline products

Reasons to buy

  • Evaluate A. Menarini Industrie Farmaceutiche Riunite Srl's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of A. Menarini Industrie Farmaceutiche Riunite Srl in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the A. Menarini Industrie Farmaceutiche Riunite Srl's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of A. Menarini Industrie Farmaceutiche Riunite Srl and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of A. Menarini Industrie Farmaceutiche Riunite Srl
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of A. Menarini Industrie Farmaceutiche Riunite Srl and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • A. Menarini Industrie Farmaceutiche Riunite Srl Snapshot
  • A. Menarini Industrie Farmaceutiche Riunite Srl Overview
    • Key Information
    • Key Facts
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Research and Development Overview
    • Key Therapeutic Areas
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products Glance
    • A. Menarini Industrie Farmaceutiche Riunite Srl - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • A. Menarini Industrie Farmaceutiche Riunite Srl - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Drug Profiles
    • (dexketoprofen + tramadol hydrochloride)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ibodutant
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • sabarubicin
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • fasitibant chloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • nepadutant
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ranolazine ER
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Analysis
    • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Target
    • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Route of Administration
    • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Molecule Type
    • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Mechanism of Action
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Recent Pipeline Updates
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Dormant Projects
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • abagovomab
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Company Statement
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • A. Menarini Industrie Farmaceutiche Riunite Srl, Key Information
  • A. Menarini Industrie Farmaceutiche Riunite Srl, Key Facts
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Indication, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Stage of Development, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Monotherapy Products in Pipeline, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Combination Treatment Modalities in Pipeline, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Partnered Products in Pipeline, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Partnered Products/ Combination Treatment Modalities, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pre-Registration, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Phase III, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Phase II, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Phase I, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Target, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Route of Administration, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Molecule Type, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Mechanism of Action, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Recent Pipeline Updates, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Dormant Developmental Projects,2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Discontinued Pipeline Products, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl, Subsidiaries

List of Figures

  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Top 10 Indication, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Stage of Development, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Monotherapy Products in Pipeline, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Partnered Products in Pipeline, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Top 10 Target, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Top 10 Route of Administration, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline by Top 10 Molecule Type, 2015
  • A. Menarini Industrie Farmaceutiche Riunite Srl - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top